¼ö¸é¹«È£Èí Áø´Ü ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2023-2030³â)
Sleep Apnea Diagnostic System Market, By Product Type (Polysomnography & Sleep Apnea Screening Devices), Share, Outlook, & Opportunity Analysis, 2023-2030
»óǰÄÚµå : 1304378
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2023³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,256,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,732,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,903,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼ö¸é¹«È£ÈíÁõÀº È£ÈíÀÌ ¸ØÃè´Ù°¡ ´Ù½Ã ½ÃÀ۵DZ⸦ ¹Ýº¹Çϴ ȣÈíÀå¾ÖÀÔ´Ï´Ù. ³ú´Â È£ÈíÀ» ÇÒ ¼ö ÀÖÀ» ¸¸Å­ ÃæºÐÈ÷ ±ú¾îÀ־ ¸öÀ» º¸È£ÇÏ·Á°í ÇÏÁö¸¸, ÀÌ·Î ÀÎÇØ Æí¾ÈÇÏ°í °Ç°­ÇÑ ¼ö¸éÀ» ¹æÇØ¹Þ°Ô µË´Ï´Ù. ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀÌ Áõ»óÀº ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ Áõ»óÀº ƯÈ÷ ó¹æµÈ Ä¡·á¹ýÀ» Àß Áö۸é ÃæºÐÈ÷ °ü¸®ÇÒ ¼ö ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ¿¡´Â Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ, ÁßÃß¼º ¼ö¸é¹«È£ÈíÁõ, º¹ÇÕ ¼ö¸é¹«È£ÈíÁõ µî ¼¼ °¡Áö À¯ÇüÀÌ ÀÖ½À´Ï´Ù. Æó¼â¼º ¼ö¸é¹«È£ÈíÁõÀÌ °¡Àå ÈçÇÑ À¯ÇüÀÔ´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ¿¡´Â ¼ö¸é´Ù¿ø°Ë»ç(PSG) Àåºñ, ¼±º°°Ë»ç Àåºñ, ¾ç¾Ð±â ¸ð´ÏÅ͸µ Àåºñ µîÀÌ ÀÖ½À´Ï´Ù. ¼ö¸é´Ù¿ø°Ë»ç´Â ´Ù¾çÇÑ ¼ö¸éÀå¾Ö¸¦ Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ¼ö¸é °Ë»ç´Ù. ÀÌ Àåºñ´Â ³úÆÄ, Ç÷Áß »ê¼Ò ³óµµ, ½É¹Ú¼ö, È£Èí, ¾È±¸ ¹× ´Ù¸®ÀÇ ¿òÁ÷ÀÓÀ» ±â·ÏÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÃÖ±Ù ¼ö³â°£ °¡Á¤¿ë ¼ö¸é °Ë»ç°¡ Å©°Ô ¹ßÀüÇÏ¿© ÀûÀýÇÑ È¯ÀÚÀÇ ¼ö¸é ¹®Á¦¸¦ Áø´ÜÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÁÖ¿ä ½ÃÀå ±â¾÷Àº ¿¬±¸°³¹ß Ȱµ¿¿¡ ÁýÁßÇÏ°í ±ÔÁ¦ ´ç±¹À¸·ÎºÎÅÍ Á¦Ç° ½ÂÀÎÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è ¼ö¸é ¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 2¿ù ¼ö¸é¹«È£ÈíÁõ Áø´Ü¿ë ÀÎÁõ ÀÇ·á±â±â¸¦ °³¹ßÇÏ´Â ¼ö¸é°úÇÐ ±â¾÷ Sunrise´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ ¹× ¼ö¸é °ü·Ã È£ÈíÀå¾Ö Áø´ÜÀ» Áö¿øÇÏ´Â ÀΰøÁö´É(AI) ±â¹Ý 2¼¼´ë °¡Á¤¿ë ¼ö¸é¹«È£ÈíÁõ °Ë»ç »ç¿ëÀ» Çã°¡Çß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. Sunrise ÆÀÀº ¼ö½Ê³â°£ ¿¬±¸µÇ¾î ¿Â ÇÏ¾Ç ¿îµ¿(MJM) »ýü ½ÅÈ£¸¦ ÅëÇØ ¼ö¸éÀ» ÃøÁ¤ÇÏ´Â »õ·Î¿î ¹æ¹ýÀ» »ç¿ëÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¼ö¸é¹«È£Èí Áø´Ü ½Ã½ºÅÛ ½ÃÀå - COVID-19 ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¼ö¸é¹«È£Èí Áø´Ü ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°, 2018-2030³â

Á¦6Àå ¼¼°èÀÇ ¼ö¸é¹«È£Èí Áø´Ü ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â

Á¦7Àå ¼¼°èÀÇ ¼ö¸é¹«È£Èí Áø´Ü ½Ã½ºÅÛ ½ÃÀå, Áö¿ªº°, 2018-2030³â

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¼½¼Ç

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Sleep apnea is a breathing disorder where breathing repeatedly stops and starts. The brain tries to protect you by waking you up enough to breathe, but this prevents restful, healthy sleep. Over time, this condition can cause serious complications. However, this condition is often very manageable, especially with close adherence to prescribed treatments. There are three types of sleep apnea; obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea is the most common type. Sleep apnea diagnostic systems include polysomnography (PSG) devices, screening devices, and actigraphy monitoring devices. Polysomnography is a sleep test used to diagnose various sleep disorders. The device is used to record brain waves, the oxygen level in the blood, heart rate and breathing, as well as eye and leg movements.

Market Dynamics

In recent years, home sleep tests have advanced significantly, and they are now widely used to diagnose sleep problems in the right patients. Thus, key market players are focusing on research and development activities and getting product approvals from the regulatory authorities, which is attributed to the growth of the global sleep apnea diagnostic system market. For instance, in February 2023, Sunrise, a sleep science company that develops a certified medical device for the diagnosis of sleep apnea, announced the U.S. Food and Drug Administration (FDA) had cleared for use its second-generation at-home sleep apnea test that uses artificial intelligence (AI) to aid in the diagnosis of obstructive sleep apnea and sleep-related breathing disorders. The Sunrise team is using a novel way to measure sleep through the bio-signal of Mandibular Jaw Movements (MJM), which has been studied for decades.

Key features of the study:

Detailed Segmentation:

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Sleep Apnea Diagnostic System Market- COVID-19 Impact Analysis

5. Global Sleep Apnea Diagnostic System Market, Product Type, 2018-2030, (US$ Billion)

6. Global Sleep Apnea Diagnostic System Market, By End User, 2018-2030, (US$ Billion)

7. Global Sleep Apnea Diagnostic System Market, By Region, 2018-2030, (US$ Billion)

8. Competitive Landscape

9. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â